206 related articles for article (PubMed ID: 27220230)
61. Planned foveal detachment technique for the resolution of diffuse diabetic macular edema.
Morizane Y; Kimura S; Hosokawa M; Shiode Y; Hirano M; Doi S; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
Jpn J Ophthalmol; 2015 Sep; 59(5):279-87. PubMed ID: 26220819
[TBL] [Abstract][Full Text] [Related]
62. ALL-PROBE VITRECTOMY DISSECTION TECHNIQUES FOR DIABETIC TRACTIONAL RETINAL DETACHMENTS: Lift and Shave.
Berrocal MH
Retina; 2018 Sep; 38 Suppl 1():S2-S4. PubMed ID: 29023269
[TBL] [Abstract][Full Text] [Related]
63. Effect of symptom duration on outcomes following vitrectomy repair of primary macula-off retinal detachments.
Kim JD; Pham HH; Lai MM; Josephson JW; Minarcik JR; Von Fricken M
Retina; 2013 Oct; 33(9):1931-7. PubMed ID: 23591530
[TBL] [Abstract][Full Text] [Related]
64. Surgical management of retinal diseases: proliferative diabetic retinopathy and traction retinal detachment.
Cruz-Iñigo YJ; Acabá LA; Berrocal MH
Dev Ophthalmol; 2014; 54():196-203. PubMed ID: 25196770
[TBL] [Abstract][Full Text] [Related]
65. [One year outcomes of pars plana vitrectomy in proliferative diabetic retinopathy].
Tadera M; Kawamura H; Fujikawa M; Kakinoki M; Sawada T; Saishin Y; Ohji M
Nippon Ganka Gakkai Zasshi; 2014 Jun; 118(6):502-7. PubMed ID: 25016792
[TBL] [Abstract][Full Text] [Related]
66. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
67. Influencing factors of low vision 2 years after vitrectomy for proliferative diabetic retinopathy: an observational study.
Wang S; Liu Y; Du Y; Bao H; Zhu J; Liu X
BMC Ophthalmol; 2023 Jul; 23(1):309. PubMed ID: 37430223
[TBL] [Abstract][Full Text] [Related]
68. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
[TBL] [Abstract][Full Text] [Related]
69. Long-term outcome after vitrectomy for diabetic macular edema.
Kralinger MT; Pedri M; Kralinger F; Troger J; Kieselbach GF
Ophthalmologica; 2006; 220(3):147-52. PubMed ID: 16679787
[TBL] [Abstract][Full Text] [Related]
70. Surgical outcomes of florid diabetic retinopathy treated with antivascular endothelial growth factor.
Couturier A; Dupas B; Guyomard JL; Massin P
Retina; 2014 Oct; 34(10):1952-9. PubMed ID: 25011026
[TBL] [Abstract][Full Text] [Related]
71. Current management of diabetic tractional retinal detachments.
Stewart MW; Browning DJ; Landers MB
Indian J Ophthalmol; 2018 Dec; 66(12):1751-1762. PubMed ID: 30451175
[TBL] [Abstract][Full Text] [Related]
72. Visual outcomes and prognostic factors following 23G vitrectomy for vitreous hemorrhage in eyes with proliferative diabetic retinopathy.
Damian I; Nicoară SD
Arq Bras Oftalmol; 2023; 86(2):105-112. PubMed ID: 35319648
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of EX-PRESS glaucoma implant in elderly diabetic patients after 23G vitrectomy.
Lyssek-Boroń A; Wylęgała A; Dobrowolski D; Kowalczyk E; Polanowska K; Wylęgała E
Clin Interv Aging; 2017; 12():653-658. PubMed ID: 28435237
[TBL] [Abstract][Full Text] [Related]
74. Rubeosis iridis after vitrectomy for diabetic retinopathy.
Helbig H; Kellner U; Bornfeld N; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 1998 Oct; 236(10):730-3. PubMed ID: 9801886
[TBL] [Abstract][Full Text] [Related]
75. Comparison of combined and sequential surgery for proliferative diabetic retinopathy: a single surgeon study.
Yang Y; Zhang J; Yan H
PLoS One; 2014; 9(9):e108933. PubMed ID: 25268829
[TBL] [Abstract][Full Text] [Related]
76. Vitrectomy for diabetic retinopathy in patients undergoing hemodialysis for associated end-stage renal failure.
Hayashi H; Kurata Y; Imanaga Y; Goya K; Oshima K
Retina; 1998; 18(2):156-9. PubMed ID: 9564697
[TBL] [Abstract][Full Text] [Related]
77. Effectiveness of intraoperative optical coherence tomography on vitrectomy for proliferative diabetic retinopathy.
Nishitsuka K; Nishi K; Yamashita H
Jpn J Ophthalmol; 2022 Nov; 66(6):527-533. PubMed ID: 36318355
[TBL] [Abstract][Full Text] [Related]
78. Surgical outcomes of vitrectomy surgery for proliferative diabetic retinopathy in patients with abnormal renal function.
Larrañaga-Fragoso P; Laviers H; McKechnie C; Zambarakji H
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):63-70. PubMed ID: 31758258
[TBL] [Abstract][Full Text] [Related]
79. Chronic myeloid leukaemia accelerates proliferative retinopathy in patients with co-existent diabetes: A risk factor not to be ignored.
Chawla R; Kumar S; Kumawat D; Azad SV; Temkar S; Jain S
Eur J Ophthalmol; 2021 Jan; 31(1):226-233. PubMed ID: 31514533
[TBL] [Abstract][Full Text] [Related]
80. [Limits and possibilities of vitreous body surgery in diabetic retinopathy].
Helbig H; Kellner U; Bornfeld N; Foerster MH
Ophthalmologe; 1996 Dec; 93(6):647-54. PubMed ID: 9081518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
